Skip to content

CyPass System Model 241-S

by Alcon Research, Ltd.

PMA P150037

Withdrawn Withdrawn in United States.

Was authorized under PMA, withdrawn

Ended

Withdrawn 29 Jul 2016

PMA

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPWD Approval withdrawn NumberP150037 Date29 Jul 2016Approval withdrawnStatusWithdrawn

Recalls

4 recalls · FDA

  • 4 recalls, same reason

    • Terminated Z-0187-2019 FDA Class I initiated 28 Aug 2018
    • Terminated Z-0188-2019 FDA Class I initiated 28 Aug 2018
    • Terminated Z-0185-2019 FDA Class I initiated 28 Aug 2018
    • Terminated Z-0186-2019 FDA Class I initiated 28 Aug 2018

    Analysis of the completed dataset from the COMPASS-XT long-term study showed that the CyPass Micro-Stent group experienced statistically significant endothelial cell loss (ECL) compared to the group who underwent cataract surgery alone.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Withdrawn

Specification

PMA

Full name
Cypass System
Trade Name
CyPass Micro-Stent
Generic Name
Intraocular pressure lowering implant
PMA Number
FDA Product Code
OGO
Device Class
Class III
Advisory Committee
Ophthalmic
FDA Decision
APWD Approval withdrawn

Other devices from Alcon Research, Ltd.

See all devices from Alcon Research, Ltd. →